Brief: Astrazeneca Reports Enhertu Recommended In EU For HER2+ Solid Tumours
26/05/2026 07:24
May 26 (Reuters) - AstraZeneca PLC AZN.L: ASTRAZENECA PLC - ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS Source text: ID:nRSZ6562Fa Further company coverage: AZN.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains